New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2013
10:04 EDTSWN, MWV, ASH, TWO, KRA, GMAN, ZIOP, MGLN, COGOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Ashland (ASH) downgraded to Neutral from Buy at Longbow... Cabot Oil & Gas (COG) downgraded to Hold from Buy at Stifel... Gordmans Stores (GMAN) downgraded to Neutral from Overweight at Piper Jaffray... Kraton Performance (KRA) downgraded to Perform from Outperform at Oppenheimer... Magellan Health (MGLN) downgraded to Market Perform from Outperform at Raymond James... MeadWestvaco (MWV) downgraded to Neutral from Buy at UBS... Southwestern Energy (SWN) downgraded to Hold from Buy at Stifel... Ziopharm (ZIOP) downgraded to Underperform from Market Perform at BMO Capital... Two Harbors (TWO) downgraded to Neutral from Buy at Compass Point... Cabot Oil & Gas (COG) downgraded to Hold from Buy at Stifel... Southwestern Energy (SWN) downgraded at Stifel.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 30, 2015
09:27 EDTZIOPOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTZIOPZiopharm-Intrexon announce collaboration with Merck KGaA for CAR-T products
ZIOPHARM Oncology (ZIOP) and Intrexon (XON) announced their oncology programs will be strengthened through Intrexon's new global collaboration focused exclusively on novel chimeric antigen receptor T-cell, or CAR-T, products with Merck Serono, the biopharmaceutical division of Merck KGaA (MKGAY). Intrexon will share the economic provisions of this collaboration, including upfront payment, milestones and royalties, equally with ZIOPHARM. Under the collaboration Merck Serono will elect CAR-T targets, two initially, for which it will provide certain research funding. Through its agreement with Intrexon, ZIOPHARM will be responsible for any additional research and development expenditures. Once these candidates reach investigational new drug stage, the programs will be transferred to Merck Serono for clinical development and commercialization. ZIOPHARM and Intrexon will also independently conduct research and development on other CAR-T candidates, with Merck having the opportunity during clinical development to opt-in. ZIOPHARM's other oncology programs will continue through its Exclusive Channel Collaboration with Intrexon.
March 27, 2015
12:28 EDTZIOPIntrexon, Ziopharm mentioned as stock picks by Bill Miller on CNBC
March 26, 2015
07:11 EDTASHGabelli to hold a conference
Subscribe for More Information
March 25, 2015
11:01 EDTZIOPZiopharm May volatility elevated at 129
Ziopharm April call option implied volatility is at 123, May is at 129, July is at 106; compared to its 26-week average of 120 according to Track Data, suggesting large April price movement.
March 24, 2015
10:39 EDTASHAshland management to meet with Jefferies
Subscribe for More Information
March 23, 2015
14:07 EDTSWNSouthwestern Energy CEO says 'don't have for sale sign up'
Subscribe for More Information
06:04 EDTZIOPStocks with implied volatility above IV index mean; ZIOP BBRY
Subscribe for More Information
March 20, 2015
16:07 EDTSWNSouthwestern Energy announces sale of conventional assets in East Texas, Arkoma
Subscribe for More Information
08:35 EDTMWVMeadWestvaco, RockTenn announce executive management team for combined company
Subscribe for More Information
08:34 EDTMWVMeadWestvaco, RockTenn announce executive team for combined company
MeadWestvaco (MWV) and Rock-Tenn (RKT) announced the executive leadership team for the combined company following the completion of the transaction. As previously announced, Steve Voorhees will serve as the new company’s CEO and John Luke will be non-executive chairman of the board. The executive leadership team announced today includes: Nina Butler, chief sustainability officer; Ward Dickson, chief financial officer; Pete Durette, chief strategy officer; Jennifer Graham-Johnson, chief human resources officer; Linda Schreiner, chief integration officer. The transaction remains on track to close in Q2 and is subject to shareholder approvals of both MWV and RockTenn, certain regulatory approvals and other customary closing conditions.
08:18 EDTMGLNLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
March 19, 2015
16:09 EDTGMANGordmans Stores sees Q1 EPS (6c)-(2c), consensus (5c)
Subscribe for More Information
16:07 EDTGMANGordmans Stores reports Q4 EPS 12c, consensus 8c
Reports Q4 revenue $203.9M, consensus $267.04M. Reports Q4 SSS down 2.7%.
11:06 EDTASHAshland management to meet with Jefferies
Subscribe for More Information
10:02 EDTSWNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:53 EDTSWNSouthwestern Energy downgraded to Neutral from Buy at Sterne Agee
Sterne Agee downgraded Southwestern due to equity dilution, the sharp increase in its debt in early 2015, and deteriorating U.S. natural gas price outlook.
08:32 EDTSWNSouthwestern Energy sells gathering assets in Northeast Pennsylvania for $500M
Southwestern Energy has executed a definitive purchase and sale agreement with Howard Midstream Energy Partners to sell Southwestern Energy's gathering assets located in Bradford and Lycoming counties in northeastern Pennsylvania for $500M. The assets include approximately 100 miles of natural gas gathering pipeline, with nearly 600 million cubic feet per day of capacity. The proceeds from the transaction will be used to substantially repay borrowings under Southwestern Energy's $500M term loan facility that matures in December 2016. The transaction is expected to close in Q2.
07:33 EDTKRAKraton developing reorganization strategy with Bain, Bloomberg says
Subscribe for More Information
05:50 EDTTWOTwo Harbors to host analyst/investor day
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use